Sign Up Today and Learn More About Hemex Health Stock
Invest in or calculate the value of your shares in Hemex Health or other pre-IPO companies through EquityZen's platform.
Hemex Health Stock (HEHE)
Develops malaria and sickle cell diagnostic devices.
About Hemex Health Stock
Founded
2016
Headquarters
Portland, OR, US
Total Funding
6.8M
Industries
Software, Artificial Intelligence, Data and Analytics
Hemex Health Press Mentions
Stay in the know about the latest news on Hemex Health
Sickle Cell Anemia Testing & Screening Market to reach USD 383 million by 2030 according to a new research ...
whatech • Dec 25, 2023
Global Sickle Cell Anemia Testing & Screening Market ...
globenewswire • Dec 25, 2023
Hemex Health awarded $3 million grant to advance commercialization of Gazelle Hb Variant Test for the U.S. market
news-medical • Mar 30, 2023
Hemex Health developing malaria detector with Navy researchers in Peru
techlinkcenter • Jul 24, 2019
Hemex Health Management
Leadership team at Hemex Health
CIO
Peter Galen
CEO
Patti White
Join now and verify your accreditation status to gain access to:
- Hemex Health current valuation
- Hemex Health stock price
- Available deals in Hemex Health and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Hemex Health stock?
Accredited investors can buy pre-IPO stock in companies like Hemex Health through EquityZen funds. These investments are made available by existing Hemex Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Hemex Health stock?
Shareholders can sell their Hemex Health stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
